GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Prolight Diagnostics AB (NGM:PRLD) » Definitions » Operating Cash Flow per Share

Prolight Diagnostics AB (NGM:PRLD) Operating Cash Flow per Share : kr-0.05 (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Prolight Diagnostics AB Operating Cash Flow per Share?

Prolight Diagnostics AB's operating cash flow per share for the three months ended in Dec. 2024 was kr-0.01. Prolight Diagnostics AB's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.05.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Prolight Diagnostics AB's Operating Cash Flow per Share or its related term are showing as below:

NGM:PRLD' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -31.5   Med: -7.5   Max: 14.7
Current: 0.7

During the past 9 years, Prolight Diagnostics AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 14.70% per year. The lowest was -31.50% per year. And the median was -7.50% per year.

NGM:PRLD's 3-Year OCF Growth Rate is ranked worse than
61.64% of 696 companies
in the Medical Devices & Instruments industry
Industry Median: 8.3 vs NGM:PRLD: 0.70

Prolight Diagnostics AB Operating Cash Flow per Share Historical Data

The historical data trend for Prolight Diagnostics AB's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prolight Diagnostics AB Operating Cash Flow per Share Chart

Prolight Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only -0.04 -0.05 - -0.10 -0.05

Prolight Diagnostics AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.02 - -0.02 -0.01

Competitive Comparison of Prolight Diagnostics AB's Operating Cash Flow per Share

For the Medical Instruments & Supplies subindustry, Prolight Diagnostics AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prolight Diagnostics AB's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Prolight Diagnostics AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Prolight Diagnostics AB's Price-to-Operating-Cash-Flow falls into.


;
;

Prolight Diagnostics AB Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Prolight Diagnostics AB's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )=Cash Flow from Operations (A: Dec. 2024 )/Shares Outstanding (Diluted Average) (A: Dec. 2024 )
=-27.946/590.466
=-0.05

Prolight Diagnostics AB's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )=Cash Flow from Operations (Q: Dec. 2024 )/Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
=-6.447/656.339
=-0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prolight Diagnostics AB Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Prolight Diagnostics AB's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Prolight Diagnostics AB Business Description

Traded in Other Exchanges
N/A
Address
Gasverksgatan 3A, Lund, SWE, 222 29
Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.